Quick Answer
Skye Bioscience, Inc. reported Total Assets of $28.31 million for fiscal year 2025.
Skye Bioscience, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $28.31M | -61.1% |
| 2024 | $72.76M | +509.4% |
| 2023 | $11.94M | +31.1% |
| 2022 | $9.11M | -7.5% |
| 2021 | $9.86M | +268.9% |
| 2020 | $2.67M | +33.8% |
| 2019 | $2.00M | +2.0% |
| 2018 | $1.96M | +251.2% |
| 2017 | $557.2K | +72.3% |
| 2016 | $323.4K | -90.8% |
| 2015 | $3.51M | +907.9% |
| 2014 | $348.3K | +139.1% |
| 2013 | $145.7K | +239.7% |
| 2012 | $42.9K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $41.32M | -49.3% | -20.8% |
| June 30, 2025 | $52.16M | -40.2% | -19.5% |
| March 31, 2025 | $64.79M | -31.7% | -11.0% |
| December 31, 2024 | $72.76M | +509.4% | -10.8% |
| September 30, 2024 | $81.54M | +422.5% | -6.6% |
| June 30, 2024 | $87.26M | +3802.7% | -8.0% |
| March 31, 2024 | $94.84M | +1967.5% | +694.2% |
| December 31, 2023 | $11.94M | +31.1% | -23.5% |
- Skye Bioscience, Inc. showed a decrease of -61.1% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, Skye Bioscience, Inc.’s total assets has grown by 65923.8% (from $42.9 thousand to $28.31 million).
- The most recent figure is from Skye Bioscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: